US OptionsDetailed Quotes
VKTX241129C49000
- 5.00
- -1.38-21.63%
15min DelayClose Nov 27 16:00 ET
5.00High5.00Low
5.00Open6.38Pre Close35 Volume41 Open Interest49.00Strike Price17.50KTurnover0.00%IV-0.94%PremiumNov 29, 2024Expiry Date5.51Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma10.38Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Viking Therapeutics Stock Discussion
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
lets gooooooo
No comment yet